Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | aurora kinase A | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | AGC family protein kinase | 0.0068 | 0.1607 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0068 | 0.1607 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0068 | 0.1607 | 1 |
Plasmodium vivax | serine/threonine protein kinase 6, putative | 0.0068 | 0.1607 | 0.1607 |
Echinococcus multilocularis | serine:threonine protein kinase 12 B | 0.0068 | 0.1607 | 0.1607 |
Echinococcus multilocularis | choline:ethanolamine kinase | 0.0281 | 1 | 1 |
Toxoplasma gondii | phosphotransferase enzyme family protein | 0.0281 | 1 | 1 |
Entamoeba histolytica | serine/threonine- protein kinase 6 , putative | 0.0068 | 0.1607 | 1 |
Echinococcus granulosus | choline:ethanolamine kinase | 0.0281 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0068 | 0.1607 | 1 |
Onchocerca volvulus | 0.0027 | 0 | 0.5 | |
Plasmodium falciparum | choline kinase | 0.0281 | 1 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0068 | 0.1607 | 1 |
Brugia malayi | serine/threonine-protein kinase 6 | 0.0068 | 0.1607 | 0.1607 |
Trypanosoma brucei | aurora B kinase | 0.0068 | 0.1607 | 1 |
Plasmodium vivax | choline kinase, putative | 0.0281 | 1 | 1 |
Entamoeba histolytica | serine/threonine protein kinase 6, putative | 0.0068 | 0.1607 | 1 |
Trypanosoma cruzi | aurora B kinase, putative | 0.0068 | 0.1607 | 1 |
Loa Loa (eye worm) | choline/ethanolamine kinase | 0.0281 | 1 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0068 | 0.1607 | 1 |
Loa Loa (eye worm) | AUR protein kinase | 0.0068 | 0.1607 | 0.1607 |
Onchocerca volvulus | Putative choline\/ethanolamine kinase | 0.0027 | 0 | 0.5 |
Leishmania major | protein kinase, putative | 0.0068 | 0.1607 | 1 |
Plasmodium falciparum | serine/threonine protein kinase, putative | 0.0068 | 0.1607 | 0.1607 |
Toxoplasma gondii | aurora kinase | 0.0068 | 0.1607 | 0.1607 |
Giardia lamblia | Aurora kinase | 0.0068 | 0.1607 | 1 |
Loa Loa (eye worm) | AUR protein kinase | 0.0068 | 0.1607 | 0.1607 |
Entamoeba histolytica | serine/threonine- protein kinase 6, putative | 0.0068 | 0.1607 | 1 |
Schistosoma mansoni | protein kinase | 0.0068 | 0.1607 | 1 |
Echinococcus multilocularis | aurora kinase A | 0.0068 | 0.1607 | 0.1607 |
Echinococcus granulosus | serine:threonine protein kinase 12 B | 0.0068 | 0.1607 | 0.1607 |
Entamoeba histolytica | protein kinase , putative | 0.0068 | 0.1607 | 1 |
Brugia malayi | serine/threonine protein kinase 6 | 0.0068 | 0.1607 | 0.1607 |
Loa Loa (eye worm) | AUR protein kinase | 0.0068 | 0.1607 | 0.1607 |
Echinococcus granulosus | aurora kinase A | 0.0068 | 0.1607 | 0.1607 |
Trichomonas vaginalis | AGC family protein kinase | 0.0068 | 0.1607 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0068 | 0.1607 | 1 |
Brugia malayi | serine/threonine kinase 12 | 0.0068 | 0.1607 | 0.1607 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 10000 nM | Enzyme Assay | BINDINGDB. | No reference |
IC50 (binding) | = 24600 nM | BindingDB_Patents: Enzyme Assay. P70S6K inhibitor compounds are diluted and plated in 96 well plates. A reaction mixture including the following components is then added to the compound plate to initiate the enzyme reaction; P70S6K (3 nM, T412E mutant, Millipore) is mixed with 24 µM ATP in an assay buffer containing 100 mM Hepes (pH 7.5), 5 mM MgCl2, 1 mM DTT, 0.015% Brij and 1 µM of the substrate peptide FITC-AHA-AKRRRLSSLRA-OH (derived from the S6 ribosomal protein sequence, FITC=fluorescein isothiocyanate, AHA=6-aminohexanoic acid). The reaction is incubated for 90 min at 25° C., before the addition of 10 mM EDTA to stop the reaction. The proportion of substrate and product (phosphorylated) peptide is analysed on a Caliper Life Sciences Lab Chip 3000, using a pressure of -1.4 psi, and upstream and downstream voltages of -3000 and -700 respectively. | ChEMBL. | No reference |
IC50 (binding) | = 24600 nM | BindingDB_Patents: Enzyme Assay. P70S6K inhibitor compounds are diluted and plated in 96 well plates. A reaction mixture including the following components is then added to the compound plate to initiate the enzyme reaction; P70S6K (3 nM, T412E mutant, Millipore) is mixed with 24 µM ATP in an assay buffer containing 100 mM Hepes (pH 7.5), 5 mM MgCl2, 1 mM DTT, 0.015% Brij and 1 µM of the substrate peptide FITC-AHA-AKRRRLSSLRA-OH (derived from the S6 ribosomal protein sequence, FITC=fluorescein isothiocyanate, AHA=6-aminohexanoic acid). The reaction is incubated for 90 min at 25° C., before the addition of 10 mM EDTA to stop the reaction. The proportion of substrate and product (phosphorylated) peptide is analysed on a Caliper Life Sciences Lab Chip 3000, using a pressure of -1.4 psi, and upstream and downstream voltages of -3000 and -700 respectively. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.